Expressing the sense of Congress that governmental entities should use a portion of the proceeds from litigation against opioid manufacturers and distributors to increase participation in drug take back programs and for the safe disposal of collected, unused medicines.

Bill 117 H.Con.Res. 42, titled "Expressing the sense of Congress that governmental entities should use a portion of the proceeds from litigation against opioid manufacturers and distributors to increase participation in drug take back programs and for the safe disposal of collected, unused medicines," is a resolution that urges government entities to allocate funds from legal actions against opioid manufacturers and distributors towards enhancing drug take back programs and ensuring the safe disposal of unused medications.

The resolution emphasizes the importance of addressing the opioid crisis by promoting responsible disposal of prescription drugs to prevent misuse and abuse. It highlights the role that government entities can play in increasing participation in drug take back programs, which provide a safe and convenient way for individuals to dispose of their unused medications.

By using a portion of the proceeds from litigation against opioid manufacturers and distributors, the resolution aims to support and expand these programs, ultimately helping to reduce the availability of unused prescription drugs that can contribute to the opioid epidemic. This approach aligns with efforts to combat the crisis by addressing both the supply and demand sides of the issue. Overall, Bill 117 H.Con.Res. 42 underscores the importance of utilizing resources from legal actions against opioid manufacturers and distributors to support initiatives that promote safe disposal of prescription drugs and increase participation in drug take back programs. It reflects a bipartisan effort to address the opioid crisis and protect public health.